|

Pregnancy and Postpartum CGM in GDM

RECRUITINGSponsored by Icahn School of Medicine at Mount Sinai
Actively Recruiting
SponsorIcahn School of Medicine at Mount Sinai
Started2025-08-05
Est. completion2026-08-05
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07174245

Summary

Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of gestational diabetes during current pregnancy
* age 18 or older
* prescribed Dexcom G7

Exclusion Criteria:

* Pregestational diabetes
* known skin adhesive allergy which inhibits ongoing use of CGM
* chronic oral steroid use.

Conditions2

DiabetesGestational Diabetes

Locations1 site

Icahn School of Medicine at Mount Sinai
New York, New York, 10029
Shaziah Hassan212-241-5355shaziah.hassan@mssm.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.